From day one, our goal has been to leverage our unique proprietary technologies and know-how to build a company that would bring safer, more cost-effective and more convenient therapeutic products to under served patient populations in both existing and emerging markets. Below you will find the latest updates for our leading indications including clinical trial results, FDA & EMA designations.